MDGL Gamma Exposure (GEX)

Net gamma exposure for Madrigal Pharmaceuticals Inc (MDGL) options was positive at the Nov 4, 2026 close, about $1.06M per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.

Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.

Upgrade now

Gamma Exposure by Strike

Showing results for MDGL, 2026-11-20(m), calls & puts

       

Gamma Exposure Stats

Showing results for MDGL, 2026-11-20(m), calls & puts



Net Gamma Exposure by Expiration

Showing results for MDGL, 2026-11-20(m), calls & puts. View all expiries

       
Expiration Net GEX Call GEX Put GEX Call Wall Put Wall Gamma Flip

MDGL Gamma Exposure FAQ

What is gamma exposure (GEX)?

Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.

Is MDGL gamma exposure positive or negative?

Madrigal Pharmaceuticals net gamma exposure was positive on Nov 4, 2026, at $1.06M. It has been positive on 20 of the last 20 trading days.

How has MDGL gamma exposure changed recently?

Madrigal Pharmaceuticals net gamma exposure went from $2.88M on Oct 7, 2026 to $1.06M on Nov 4, 2026. See the MDGL gamma exposure history for a longer view.

What is Madrigal Pharmaceuticals Inc?

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver...

Give feedback on this chart